Regulation of Protein Synthesis by Glucose

葡萄糖对蛋白质合成的调节

基本信息

  • 批准号:
    10685894
  • 负责人:
  • 金额:
    $ 6.98万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2020
  • 资助国家:
    美国
  • 起止时间:
    2020-09-01 至 2023-08-31
  • 项目状态:
    已结题

项目摘要

PROJECT SUMMARY/ABSTRACT Skeletal muscle loss is associated with aging and various disease states. The mechanistic Target of Rapamycin in Complex 1 (mTORC1) is a protein kinase that acts to upregulate skeletal muscle protein synthesis and thereby promote muscle growth. Adenosine monophosphate-activated protein kinase (AMPK), a nutrient sensor, inhibits mTORC1 during nutrient depletion and thereby inhibits cellular growth. Similarly, the Sestrin family of proteins (Sestrins1-3) are leucine sensors that act to suppress mTORC1 by binding to and inhibiting the mTORC1 activating complex referred to as GAP activity toward Rags (GATOR2). Interestingly, the Sestrins bind not only to GATOR2 but also AMPK, suggesting that they may mediate leucine-induced activation of mTORC1 through multiple mechanisms. In novel preliminary studies presented herein, I show that the Sestrins mediate not only leucine, but also glucose signaling to mTORC1. However, which of the three Sestrins mediates glucose-induced regulation of mTORC1 is unknown. Moreover, whether glucose-induced activation of mTORC1 is mediated through the Sestrin-GATOR2 complex and/or the Sestrin-AMPK complex is unexplored. Previous studies have shown that AMPK is not only regulated by glucose but that it also regulates glucose metabolism, e.g. it upregulates hexokinase 2 (HKII) expression, suppresses glycogen synthesis, and promotes glycogenolysis. In novel preliminary studies presented herein, I show a specific interaction of Sestrin3 with AMPK and also show that Sestrin3 associates with HKII. Based on these findings, I propose to test the hypothesis that glucose acts through Sestrin3 and HKII to both stimulate mTORC1 activity and promote glycogenolysis. By using knockdown and overexpression cell culture and rodent models as well as advanced microscopy techniques I will elucidate the mechanisms through which glucose acts to modulate skeletal muscle protein synthesis and glucose metabolism. It is anticipated that delineation of the molecular markers associated with glucose-mediated stimulation of skeletal muscle metabolism will provide novel targets for future studies as well as targets for pharmaceutical manipulation.
项目总结/文摘

项目成果

期刊论文数量(5)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Tissue-specific expression differences in Ras-related GTP-binding proteins in male rats.
  • DOI:
    10.14814/phy2.15928
  • 发表时间:
    2024-02
  • 期刊:
  • 影响因子:
    2.5
  • 作者:
  • 通讯作者:
LAT1 Protein Content Increases Following 12 Weeks of Resistance Exercise Training in Human Skeletal Muscle.
  • DOI:
    10.3389/fnut.2020.628405
  • 发表时间:
    2020
  • 期刊:
  • 影响因子:
    5
  • 作者:
    Roberson PA;Mobley CB;Romero MA;Haun CT;Osburn SC;Mumford PW;Vann CG;Greer RA;Ferrando AA;Roberts MD
  • 通讯作者:
    Roberts MD
An intron variant of the GLI family zinc finger 3 (GLI3) gene differentiates resistance training-induced muscle fiber hypertrophy in younger men.
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Paul A Roberson其他文献

Paul A Roberson的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Paul A Roberson', 18)}}的其他基金

Regulation of Protein Synthesis by Glucose
葡萄糖对蛋白质合成的调节
  • 批准号:
    10252815
  • 财政年份:
    2020
  • 资助金额:
    $ 6.98万
  • 项目类别:

相似海外基金

Pharmacological targeting of AMP-activated protein kinase for immune cell regulation in Type 1 Diabetes
AMP 激活蛋白激酶对 1 型糖尿病免疫细胞调节的药理学靶向
  • 批准号:
    2867610
  • 财政年份:
    2023
  • 资助金额:
    $ 6.98万
  • 项目类别:
    Studentship
Establishing AMP-activated protein kinase as a regulator of adipose stem cell plasticity and function in health and disease
建立 AMP 激活蛋白激酶作为脂肪干细胞可塑性和健康和疾病功能的调节剂
  • 批准号:
    BB/W009633/1
  • 财政年份:
    2022
  • 资助金额:
    $ 6.98万
  • 项目类别:
    Fellowship
Determining the role of AMP-activated protein kinase in the integration of skeletal muscle metabolism and circadian biology
确定 AMP 激活蛋白激酶在骨骼肌代谢和昼夜节律生物学整合中的作用
  • 批准号:
    532989-2019
  • 财政年份:
    2021
  • 资助金额:
    $ 6.98万
  • 项目类别:
    Postdoctoral Fellowships
Metabolic control of integrin membrane traffic by AMP-activated protein kinase controls cell migration.
AMP 激活的蛋白激酶对整合素膜运输的代谢控制控制着细胞迁移。
  • 批准号:
    459043
  • 财政年份:
    2021
  • 资助金额:
    $ 6.98万
  • 项目类别:
    Studentship Programs
Determining the role of AMP-activated protein kinase in the integration of skeletal muscle metabolism and circadian biology
确定 AMP 激活蛋白激酶在骨骼肌代谢和昼夜节律生物学整合中的作用
  • 批准号:
    532989-2019
  • 财政年份:
    2020
  • 资助金额:
    $ 6.98万
  • 项目类别:
    Postdoctoral Fellowships
The Role of AMP-activated Protein Kinase in GVHD-causing T Cells
AMP 激活的蛋白激酶在引起 GVHD 的 T 细胞中的作用
  • 批准号:
    10561642
  • 财政年份:
    2019
  • 资助金额:
    $ 6.98万
  • 项目类别:
Determining the role of AMP-activated protein kinase in the integration of skeletal muscle metabolism and circadian biology
确定 AMP 激活蛋白激酶在骨骼肌代谢和昼夜节律生物学整合中的作用
  • 批准号:
    532989-2019
  • 财政年份:
    2019
  • 资助金额:
    $ 6.98万
  • 项目类别:
    Postdoctoral Fellowships
Treating Diabetic Inflammation using AMP-Activated Protein Kinase Activators
使用 AMP 激活的蛋白激酶激活剂治疗糖尿病炎症
  • 批准号:
    2243045
  • 财政年份:
    2019
  • 资助金额:
    $ 6.98万
  • 项目类别:
    Studentship
The Role of AMP-activated Protein Kinase in GVHD-causing T Cells
AMP 激活的蛋白激酶在引起 GVHD 的 T 细胞中的作用
  • 批准号:
    10359032
  • 财政年份:
    2019
  • 资助金额:
    $ 6.98万
  • 项目类别:
Investigating the therapeutic potential of AMP-activated protein kinase in myotonic dystrophy type 1
研究 AMP 激活蛋白激酶在 1 型强直性肌营养不良中的治疗潜力
  • 批准号:
    428988
  • 财政年份:
    2019
  • 资助金额:
    $ 6.98万
  • 项目类别:
    Studentship Programs
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了